Steris misses, reaffirms guidance, eyes $1B buyback
STERIS reports fiscal Q4 2026 EPS $2.83 (+3% YoY) on revenue $1.6B (+7% YoY), both missing estimates
- Fiscal 2026 revenue rose 9% to $5.9B, according to the company’s full-year financial results.
- STERIS launched a new $1B share repurchase program alongside its fiscal 2026 results announcement.
- Fiscal 2027 guidance calls for 7–8% revenue growth compared with the prior fiscal year period.
- Fiscal 2027 adjusted EPS guidance is $11.10–$11.30, as outlined alongside the fiscal 2026 Q4 results.
No comments:
Post a Comment
Note: Only a member of this blog may post a comment.